Chronic Total Occlusions (CTO): 60 Second Insights
Published: 08 March 2018
-
Views:
2186 -
Likes:
7
-
Views:
2186 -
Likes:
7
-
Up Next
-
27sPart 2 | Session 4 Emmanouil Brilakis
-
1m 36sPart 2 | Session 5 Carlos Di Mario
-
55sPart 2 | Session 6 Patrick Serruys
-
55sPart 2 | Session 7 Gerald Werner
-
25sPart 3 | Session 1 Ajay Kirtane
-
46sPart 3 | Session 2 Simon Walsh
-
1mPart 3 | Session 3 Paul Knaapen
-
35sPart 3 | Session 4 Emmanouil Brilakis
-
1m 9sPart 3 | Session 5 Carlos Di Mario
-
57sPart 3 | Session 6 Patrick Serruys
-
1m 12sPart 3 | Session 7 Gerald Werner
-
46sPart 4 | Session 1 Ajay Kirtane
-
1m 6sPart 4 | Session 2 Simon Walsh
-
1m 7sPart 4 | Session 3 Paul Knaapen
-
46sPart 4 | Session 4 Emmanouil Brilakis
-
1m 11sPart 4 | Session 5 Patrick Serruys
-
1m 24sPart 4 | Session 6 Gerald Werner
-
38sPart 5 | Session 1 Ajay Kirtane
-
46sPart 5 | Session 2 Simon Walsh
-
55sPart 5 | Session 3 Paul Knaapen
-
41sPart 5 | Session 4 Emmanouil Birlakis
-
56sPart 5 | Session 5 Carlos Di Mario
-
50sPart 5 | Session 6 Patrick Serruys
-
47sPart 5 | Session 7 Gerald Werner
-
42sPart 6 | Session 1 Ajay Kirtane
-
1m 1sPart 6 | Session 2 Simon Walsh
-
1m 2sPart 6 | Session 3 Paul Knaapen
-
35sPart 6 | Session 4 Emmanouil Birkalis
-
40sPart 6 | Session 5 Carlos Di Mario
-
1m 18sPart 6 | Session 6 Patrick Serruys
-
1m 7sPart 6 | Session 7 Gerald Werner
-
57sPart 7 | Session 1 Ajay Kirtane
-
1m 15sPart 7 | Session 2 Simon Walsh
-
1m 5sPart 7 | Session 3 Paul Knaapen
-
49sPart 7 | Session 4 Emmanouil Birkalis
-
1m 25sPart 7 | Session 5 Carlos Di Mario
-
1m 36sPart 7 | Session 6 Patrick Serruys
-
1m 24sPart 7 | Session 7 Gerald Werner
-
45sPart 8 | Session 1 Ajay Kirtane
-
37sPart 8 | Session 2 Simon Walsh
-
1mPart 8 | Session 3 Paul Knaapen
-
37sPart 8 | Session 4 Emmanouil Birlakis
-
1m 4sPart 8 | Session 5 Carlos Di Mario
-
1m 5sPart 8 | Session 6 Patrick Serruys
-
1m 7sPart 8 | Session 7 Gerald Werner
-
48sPart 9 | Session 1 Ajay Kirtane
-
52sPart 9 | Session 2 Simon Walsh
-
1m 4sPart 9 | Session 3 Paul Knaappen
-
53sPart 9 | Session 4 Emmanouil Brilakis
-
1m 7sPart 9 | Session 5 Patrick Serruys
-
1m 18sPart 9 | Session 6 Carlos Di Mario
-
1m 7sPart 9 | Session 7 Gerald Werner
-
37sPart 1 Ajay Kirtane Ajay J Kirtane
-
52sPart 2 | Session 1 Ajay Kirtane Ajay J Kirtane
-
1mPart 2 | Session 2 Simon Walsh Simon J Walsh
Overview
A series of 60-second interviews where Ajay Kirtane, Simon Walsh, Paul Knappen, Emmanouil Brilakis, Carlos Di Mario, Partick Serruys and Gerald Werner provide their thoughts on CTOs.
More from this programme
Part 1
Are CTOs important to the management of angina in your patients?
1 session | |
Ajay Kirtane | Watch now |
Part 2
What trials are needed to advance the CTO field?
Part 3
What is your preferred imaging modality for CTOs?
Part 4
What is your preferred CTO wire strategy, and why?
Part 5
What is the biggest advance in CTO treatment in the past 5 years?
Part 6
What devices should be developed to further advance CTO management?
Part 7
The data for CTO is mixed, with clinical trials showing no clear benefit, should we keep on doing CTO's?
Part 8
Retrograde or anterograde? What is your preferred strategy?
Part 9
How would you recommend someone starts a CTO program?
Faculty Biographies
Paul Knaapen
Interventional Cardiologist and Professor
Personal History
Dr Paul Knaapen is an Interventional Cardiologist, the Director of Cardiac PET/CT and a Professor of Interventional Cardiology at Amsterdam UMC, Netherlands. 4
Academic History
Dr Knaapen received his M.D. from the VU University School of Medicine. He then completed his internship, residency and interventional cardiology fellowship at the VU University Medical Center.5
Career Overview
Dr Knaapen is Professor of Cardiac Intervention and Imaging, Division of Cardiology at the VU University Medical Center, where his major research interest is the clinical value of non‐invasive cardiac imaging, with a particular focus on hybrid PET/CT and chronic total occlusions (CTOs).5
As a clinical researcher, he has co-authored 223 peer-reviewed articles and participated in 7…